ClinicalTrials.Veeva

Menu

COVID-19 Risk Stratification

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere
Coronavirus

Study type

Observational

Funder types

Other

Identifiers

NCT04339387
2020P000944

Details and patient eligibility

About

The investigators seek to derive and validate a clinically useful risk score for patients with Coronavirus Disease 2019 to aide clinicians in the safe discharge of patients.

Full description

The investigators a-priori plan the following analysis:

  1. Derivation and Retrospective Validation.

    • Select all adult patients with a positive reverse transcription polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 beginning March 1, 2020 until approximately 1000 patients are included.
    • Use 75% of this cohort to develop a simple risk-score that prognosticates a patient's suitability for discharge (no supplemental oxygen, no intensive care unit, and no death). Use multivariable logistic regression with forward selection informed by clinical judgement to choose variables a priori that emphasizes readily available data and easy calculation for use at the point of care.
    • Use 25% of this cohort to retrospectively validate the risk-score.
  2. Prospective Validation.

    • Select all adult patients with a positive reverse transcription polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 as soon as the derivation cohort in step 1 is assembled. Include approximately 250 patients.
    • Use this sample to prospectively validate the risk-score developed in part 1.

Enrollment

1,326 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Positive reverse transcription polymerase chain reaction for severe acute respiratory syndrome coronavirus 2
  • Age 18 and older

Exclusion criteria

  • None

Trial design

1,326 participants in 2 patient groups

Coronavirus Disease 2019 positive, suitable for discharge
Description:
Patients with Coronavirus Disease 2019 who do not require supplemental oxygen, do not require intensive care unit-level care, and do not die.
Coronavirus Disease 2019 positive, not suitable for discharge
Description:
Patients with Coronavirus Disease 2019 who do require supplemental oxygen, do require intensive care unit-level care, or do die.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems